Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 500-506

  Yan, Andrew T ^a   Yan, Raymond T ^a   Tan, Mary ^a   Senaratne, Mano ^b   Fitchett, David H ^a   Langer, Anatoly ^a   Goodman, Shaun G ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ALGORITHM; ARTICLE; AUTOMATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RISK ASSESSMENT; ST SEGMENT; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; PROGNOSIS; SYNDROME; TIME FACTORS;

EID: 33947416179     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.02.003     Document Type: Article

References (35)

1. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 106 (2002) 1883-1890
2. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 (2002) 1809-1840
3. Boersma E., Pieper K.S., Steyerberg E.W., et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 101 (2000) 2557-2567
4. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
5. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 163 (2003) 2345-2353
6. de Araujo Goncalves P., Ferreira J., Aguiar C., et al. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 26 (2005) 865-872
7. Wong C.K., and White H.D. Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes. Eur Heart J 26 (2005) 851-852
8. Yan A.T., Yan R.T., Tan M., et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. Am J Cardiol 96 (2005) 913-916
9. Hyde T.A., French J.K., Wong C.K., et al. Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression. Am J Cardiol 84 (1999) 379-385
10. Cannon C.P., McCabe C.H., Stone P.H., et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG ancillary substudy. J Am Coll Cardiol 30 (1997) 133-140
11. Savonitto S., Ardissino D., Granger C.B., et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 281 (1999) 707-713
12. Diderholm E., Andrén B., Frostfeldt G., et al. ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease. Eur Heart J 23 (2002) 41-49
13. Cohn P.F., Fox K.M., and Daly C. Silent myocardial ischemia. Circulation 108 (2003) 1263-1277
14. Krucoff M.W., Johanson P., Baeza R., et al. Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. Circulation 110 (2004) e533-e539
15. Gottlieb S.O., Weisfeldt M.L., Ouyang P., et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 314 (1986) 1214-1219
16. Langer A., Freeman M.R., and Armstrong P.W. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 13 (1989) 1495-1502
17. Langer A., Minkowitz J., Dorian P., et al. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol 20 (1992) 1313-1317
18. Andersen K., Eriksson P., and Dellborg M. Non-invasive risk stratification within 48 h of hospital admission in patients with unstable coronary disease. Eur Heart J 18 (1997) 780-788
19. Holmvang L., Andersen K., Dellborg M., et al. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease. Am J Cardiol 83 (1999) 667-674
20. Norgaard B.L., Andersen K., Dellborg M., et al. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia. J Am Coll Cardiol 33 (1999) 1519-1527
21. Jernberg T., Lindahl B., and Wallentin L. The combination of a continuous 12-lead ECG and troponin T; a valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG. Eur Heart J 21 (2000) 1464-1472
22. Akkerhuis K.M., Klootwijk P.A., Lindeboom W., et al. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. Eur Heart J 22 (2001) 1997-2006
23. Romeo F., Rosano G.M., Martuscelli E., et al. Unstable angina: role of silent ischemia and total ischemic time (silent plus painful ischemia), a 6-year follow-up. J Am Coll Cardiol 19 (1992) 1173-1179
24. Pozzati A., Bugiardini R., Borghi A., et al. Transient ischaemia refractory to conventional medical treatment in unstable angina: angiographic correlates and prognostic implications. Eur Heart J 13 (1992) 360-365
25. Goodman S.G., Fitchett D., Armstrong P.W., et al. Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Circulation 107 (2003) 238-244
26. Yan A.T., Jong P., Yan R.T., et al. Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndromes. Am Heart J 148 (2004) 1020-1027
27. Goodman S.G., Barr A., Sobtchouk A., et al. Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. J Am Coll Cardiol 36 (2000) 1507-1513
28. Fitchett D.H., Langer A., Armstrong P.W., et al. Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial. Am Heart J 151 (2006) 373-379
29. Patel D.J., Knight C.J., Holdright D.R., et al. Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST segment monitoring. Eur Heart J 19 (1998) 240-249
30. Norgaard B.L., Andersen K., Thygesen K., et al. Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. Heart 90 (2004) 739-744
31. Patel D.J., Gomma A.H., Knight C.J., et al. Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina? An observational study of myocardial ischaemia and its relation to coronary anatomy. Eur Heart J 22 (2001) 1991-1996
32. Armstrong P.W., Fu Y., Chang W.C., et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 98 (1998) 1860-1868
33. Jernberg T., Abrahamsson P., Lindahl B., et al. Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment. Eur Heart J 23 (2002) 1093-1101
34. Goodman S.G., Bozovich G.E., Tan M., et al. The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy. Am Heart J 151 (2006) 791-797
35. Klootwijk P., Meij S., von Es G.A., et al. Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina. Eur Heart J 18 (1997) 931-940